All In MedTech

FDA Clearance Tracker · P010032-S012

GENESIS NEUROSTIMULATION SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Nov 9, 2004 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Nov 9, 2004

Approved

Time to decision

183 days

Received May 10, 2004. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P010032-S012
Device name
GENESIS NEUROSTIMULATION SYSTEM
Applicant location
Plano, TX
Received
May 10, 2004
Decided
Nov 9, 2004
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P010032

Device type

Device class
Class III

Every decision under product code LGW

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE GENESIS RC NEUROSTIMULATION SYSTEM, MODEL 3708, AND THE GENESIS RC DUAL (IPG) SYSTEM, MODEL 3744, WHICH ARE INDICATED AS AN AID IN THE MANAGEMENT OF CHRONIC INTRACTABLE PAIN OF THE TRUNK AND/OR LIMBS, INCLUDING UNILATERAL OR BILATERAL PAIN ASSOCIATED WITH FAILED BACK SURGERY SYNDROME, INTRACTABLE LOW BACK PAIN AND LEG PAIN.

Source documents

Other decisions for ABBOTT MEDICAL

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.